Section 3 of Public Act 20-4 allows pharmacists, under certain circumstances, to prescribe and dispense diabetic ketoacidosis device, insulin drug or glucagon drug, and any necessary diabetes devices to patients in need of the medication or device.
The law allows pharmacists to prescribe and dispense up to a 30-day supply of:
- Diabetic ketoacidosis devices,
- Insulin drugs or glucagon drugs, and
- Any diabetes devices.
The medication or device may be prescribed and dispensed by a pharmacist under the following conditions:
- The patient informs the pharmacist that they have less than a 7-day supply of the medication or device,
- The pharmacist determines that the patient will likely suffer significant physical harm within seven days if they do not obtain an additional supply of the medication or device, and
- The pharmacist reviews the Connecticut Prescription Monitoring and Reporting System (CPMRS) and determines that no pharmacist has prescribed and dispensed a supply of the medication or device to the patient within the last year,
- To ensure that a pharmacist did not prescribe the medication or device within the last year, the pharmacist must contact the pharmacy that filled the most recent prescription based on information in the CPMRS or on the medication or device's prescription label.
Within 72 hours of the medication or device being prescribed or dispensed, the pharmacist, or the pharmacist's representative, must notify the practitioner who recently prescribed the medication or device.